Bank of New York Mellon’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.8K | Hold |
11,086
| – | – | ﹤0.01% | 4068 |
|
|
2025
Q1 | $41.5K | Sell |
11,086
-2
| -0% | -$7 | ﹤0.01% | 4042 |
|
|
2024
Q4 | $112K | Hold |
11,088
| – | – | ﹤0.01% | 4000 |
|
|
2024
Q3 | $138K | Hold |
11,088
| – | – | ﹤0.01% | 3961 |
|
|
2024
Q2 | $144K | Sell |
11,088
-21,383
| -66% | -$278K | ﹤0.01% | 3985 |
|
|
2024
Q1 | $735K | Sell |
32,471
-676
| -2% | -$15.3K | ﹤0.01% | 3307 |
|
|
2023
Q4 | $430K | Sell |
33,147
-10,430
| -24% | -$135K | ﹤0.01% | 3630 |
|
|
2023
Q3 | $876K | Sell |
43,577
-464
| -1% | -$9.33K | ﹤0.01% | 3229 |
|
|
2023
Q2 | $1.18M | Buy |
44,041
+13,743
| +45% | +$369K | ﹤0.01% | 3099 |
|
|
2023
Q1 | $1.77M | Buy |
30,298
+1,439
| +5% | +$84K | ﹤0.01% | 2867 |
|
|
2022
Q4 | $1.47M | Buy |
28,859
+8,926
| +45% | +$455K | ﹤0.01% | 3008 |
|
|
2022
Q3 | $1.63M | Buy |
19,933
+841
| +4% | +$68.9K | ﹤0.01% | 2961 |
|
|
2022
Q2 | $1.29M | Sell |
19,092
-701
| -4% | -$47.4K | ﹤0.01% | 3076 |
|
|
2022
Q1 | $2.19M | Sell |
19,793
-43
| -0.2% | -$4.75K | ﹤0.01% | 2880 |
|
|
2021
Q4 | $1.91M | Sell |
19,836
-331
| -2% | -$31.9K | ﹤0.01% | 3023 |
|
|
2021
Q3 | $1.76M | Buy |
20,167
+897
| +5% | +$78.3K | ﹤0.01% | 3056 |
|
|
2021
Q2 | $2.98M | Sell |
19,270
-2,047
| -10% | -$317K | ﹤0.01% | 2750 |
|
|
2021
Q1 | $3.37M | Sell |
21,317
-614
| -3% | -$96.9K | ﹤0.01% | 2635 |
|
|
2020
Q4 | $5.09M | Sell |
21,931
-1,170
| -5% | -$272K | ﹤0.01% | 2348 |
|
|
2020
Q3 | $5.06M | Buy |
23,101
+1,767
| +8% | +$387K | ﹤0.01% | 2210 |
|
|
2020
Q2 | $6.06M | Sell |
21,334
-495
| -2% | -$141K | ﹤0.01% | 2121 |
|
|
2020
Q1 | $6.29M | Buy |
21,829
+2,423
| +12% | +$698K | ﹤0.01% | 1958 |
|
|
2019
Q4 | $5.58M | Buy |
19,406
+3,387
| +21% | +$974K | ﹤0.01% | 2282 |
|
|
2019
Q3 | $2.31M | Buy |
16,019
+576
| +4% | +$83.1K | ﹤0.01% | 2673 |
|
|
2019
Q2 | $1.39M | Buy |
15,443
+844
| +6% | +$75.9K | ﹤0.01% | 3012 |
|
|
2019
Q1 | $1.28M | Buy |
14,599
+38
| +0.3% | +$3.33K | ﹤0.01% | 3019 |
|
|
2018
Q4 | $2.05M | Sell |
14,561
-12
| -0.1% | -$1.69K | ﹤0.01% | 2709 |
|
|
2018
Q3 | $3.72M | Buy |
14,573
+305
| +2% | +$77.9K | ﹤0.01% | 2534 |
|
|
2018
Q2 | $3.64M | Buy |
14,268
+3,128
| +28% | +$797K | ﹤0.01% | 2546 |
|
|
2018
Q1 | $2.24M | Buy |
11,140
+267
| +2% | +$53.8K | ﹤0.01% | 2742 |
|
|
2017
Q4 | $1.57M | Sell |
10,873
-48
| -0.4% | -$6.91K | ﹤0.01% | 2981 |
|
|
2017
Q3 | $1.8M | Buy |
10,921
+76
| +0.7% | +$12.5K | ﹤0.01% | 2897 |
|
|
2017
Q2 | $1.47M | Sell |
10,845
-1,262
| -10% | -$171K | ﹤0.01% | 3027 |
|
|
2017
Q1 | $2.33M | Buy |
12,107
+4,621
| +62% | +$890K | ﹤0.01% | 2759 |
|
|
2016
Q4 | $1.06M | Buy |
7,486
+1,632
| +28% | +$230K | ﹤0.01% | 3229 |
|
|
2016
Q3 | $854K | Sell |
5,854
-917
| -14% | -$134K | ﹤0.01% | 3258 |
|
|
2016
Q2 | $682K | Buy |
6,771
+279
| +4% | +$28.1K | ﹤0.01% | 3379 |
|
|
2016
Q1 | $869K | Sell |
6,492
-461
| -7% | -$61.7K | ﹤0.01% | 3147 |
|
|
2015
Q4 | $1.38M | Sell |
6,953
-14
| -0.2% | -$2.78K | ﹤0.01% | 2939 |
|
|
2015
Q3 | $1.1M | Sell |
6,967
-587
| -8% | -$92.7K | ﹤0.01% | 3105 |
|
|
2015
Q2 | $3.08M | Buy |
7,554
+2,144
| +40% | +$875K | ﹤0.01% | 2643 |
|
|
2015
Q1 | $2.48M | Buy |
5,410
+1,208
| +29% | +$555K | ﹤0.01% | 2710 |
|
|
2014
Q4 | $2.36M | Buy |
4,202
+10
| +0.2% | +$5.61K | ﹤0.01% | 2763 |
|
|
2014
Q3 | $2.2M | Buy |
4,192
+1,027
| +32% | +$538K | ﹤0.01% | 2814 |
|
|
2014
Q2 | $2.21M | Sell |
3,165
-489
| -13% | -$341K | ﹤0.01% | 2855 |
|
|
2014
Q1 | $1.69M | Buy |
3,654
+1,858
| +103% | +$861K | ﹤0.01% | 2981 |
|
|
2013
Q4 | $617K | Buy |
+1,796
| New | +$617K | ﹤0.01% | 3493 |
|